Doximity to Acquire Amion, Leader in Physician Scheduling
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- US stock futures rise after previous session's selloff
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Doximity Inc (DOCS) PT Lowered to $70 at Needham & Company
February 9, 2022 6:58 AM ESTNeedham & Company analyst Scott Berg lowered the price target on Doximity Inc (NYSE: DOCS) to $70.00 (from $90.00) while maintaining a Buy rating following results.
The analyst commented, "Doximity reported its biggest revenue outperformance to date in 3QF22 as its customers increased spend that converted... More
